Previous Close | 0.2400 |
Open | 0.2400 |
Bid | 0.0000 |
Ask | 4.4500 |
Strike | 180.00 |
Expire Date | 2024-06-21 |
Day's Range | 0.2400 - 0.2400 |
Contract Range | N/A |
Volume | |
Open Interest | 42 |
Besides Wall Street's top -and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.